![](/img/cover-not-exists.png)
Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
Ray‐Coquard, Isabelle, Cibula, David, Mirza, Mansoor R, Reuss, Alexander, Ricci, Caterina, Colombo, Nicoletta, Koch, Horst, Goffin, Frédéric, González‐Martin, Antonio, Ottevanger, Petronella B., BaumaLanguage:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.32606
Date:
August, 2019
File:
PDF, 1.12 MB
english, 2019